NCT03806049 2021-07-15Trial Comparing Niraparib-bevacizumab-Dostarlimab and Niraparib-bevacizumab to Standard of Care in Recurrent Ovarian CancerNordic Society of Gynaecological Oncology - Clinical Trials UnitPhase 3 Withdrawn
NCT00693342 2020-02-24Vaccine Therapy and OPT-821 or OPT-821 Alone in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer in Complete RemissionGOG FoundationPhase 3 Withdrawn
NCT02392676 2016-05-02Olaparib Maintenance Treatment Versus Placebo in Patients With PSR Ovarian Cancer Who Are in CR or PR to Platinum-based Chemotherapy and Whose Tumours Carry sBRCAm or HRR-associated Genes MutationsAstraZenecaPhase 3 Withdrawn
NCT01492920 2014-12-31Acetyl-L-Carnitine Hydrochloride in Preventing Peripheral Neuropathy in Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing ChemotherapyGOG FoundationPhase 3 Withdrawn